You are here : ERS EU ACTIVITIES EU-funded collaborative research ERS involvement in EU-funded collaborative research

ERS involvement in EU-funded collaborative research

Achieving a substantial enhancement of research is one of the key policy aims of the European Union and the Seventh Framework Programme (FP7). The FP7 runs between 2007 and 2013. It builds on the successes and experience of previous FPs which have grown in ambition over the years. It represents a substantial and crucial component of the European research effort. Below is a list of EU-funded collaborative research projects, from both FP6 (2002 -2006) and FP7 (2007-2013), that have involved ERS or ELF as partner.

  • FP7 Projects

    AirPROM

    This consortium, Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling (AirPROM), brings together the existing clinical consortia (EvA FP7, U-BIOPRED IMI and BTS Severe Asthma), and expertise in physiology, radiology, image analysis, bioengineering, data harmonization, data security and ethics, computational modelling and systems biology. We shall develop an integrated multi-scale model building upon existing models.

    		 Airprom_logo

    TB PAN NET

    Pan ‐European  network  for study  and   clinical management of  drug  resistant   tuberculosis (TB PAN NET) aims at addressing the challenge of multidrug‐resistant tuberculosis (MDR ‐TB) that faces Europe by establishing a network of expert partners who possess extensive experience in the conduct of basic and clinical research related to MD R ‐TB, TB control and molecular epidemiology.

    		 tbpannet

  • IMI Projects

    The Innovative Medicines Initiative is Europe's largest public-private partnership aiming to improve the drug development process by supporting a more efficient discovery and development of better and safer medicines for patients.

    PROactive

    The PROactive project aims to develop validation and use of patient reported outcome (PRO) tools to investigate dimensions of physical activity that are judged as being essential by patients living with COPD. A better understanding of all relevant dimensions (symptoms, distress, etc.) of physical activity that are meaningful to COPD patients will help describe the patients' experience of COPD. PROactive will be developed with input from the regulatory authorities, such as the European Medicines Agency (EMA). Once appropriately validated, PROactive will be used to evaluate the benefit of new treatments such as new medicinal products for COPD patients.

    		 logoproactive

    U-BIOPRED

    U-BIOPRED (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes) is a research project to understand more about severe asthma that involves scientists from universities, research institutes, the pharmaceutical industry and small companies.

    		 logo

  • FP6 Projects

    GRACE

    The Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe (GRACE) project aims to integrate and coordinate the activities of physicians and scientists from many institutions in 14 European countries to combat antibiotic resistance in community-acquired lower respiratory tract infections.

    		 LogoGRACEsmall